Sean Cole
π€ SpeakerAppearances Over Time
Podcast Appearances
Anyway, that's why Scott, when he talks about these drugs, is he's pretty circumspect.
He'll name a drug and then be like...
I mean, if you were potentially able to extrapolate that connotation, because nobody wants to come right out and say like, you know, take, you'll definitely sleep through the night at all.
You know, they want some plausible deniability.
Another thing the FDA very much wants to avoid is christening a new drug with a name that sounds or even looks too much like a drug that's already out there, which is a big deal.
in terms of our actual physical safety.
Medication errors kill people, and sometimes it's because of that look-alike, sound-alike problem.
And there's this sort of poster case that people point to regarding that kind of mix-up.
In short, this one patient was admitted to the hospital.
This is like the late 80s, early 90s.
They had a lot of health issues, including an ulcer for which the doctor prescribed Losec.
But the attending nurse gave her Lasix and the patient ultimately died.
So the FDA got involved and said, you know, you got to change one of these names.
And somehow it was decided that Losec would be the one to change.